11th Annual Biomarkers Congress 2016

Over 250 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions

Over 55 presentations, case studies and panel discussions focused on the key issues in biomarker research, companion diagnostics, personalised medicine and clinical biomarkers

6 Interactive Streams:

  • Biomarkers in Drug Discovery and Development
  • Personalised Medicine, Companion Diagnostics & Patient Testing
  • Biomarker Discovery, Verification & Validation
  • Innovations In Biomarker Research
  • Biomarker: Clinical Development & Clinical Trials
  • Clinical Diagnostics, NGS & Genomic Markers   

14 pre-scheduled one to one meetings, exhibition and informal networking opportunities

Oxford Global Conferences are proud to present the 11th Annual Biomarkers Congress, taking place on the 25th & 26th February 2016 at the Manchester Central Convention Complex, Manchester, UK.

In line with the current industry trends day one of the congress will focus on identifying safety biomarkers for the detection of drug-induced toxicity, using biomarkers through various stages of R&D and the translation of biomarkers from discovery staged through to exploration. The companion diagnostics & personalised medicine stream will discuss the current updates in companion diagnostics developments, regulatory updates and the future of targeted therapy, precision medicine & patient self-monitoring in healthcare.

On day two of the congress experts will discuss novel biomarker discoveries in a range of therapeutic areas such as immune-oncology, CNS diseases, neuroscience & psychiatry. Following on from discovery experts will discuss verification, validation of biomarkers & biomarker assays. The innovation stream will discuss novel biomarker technologies, platforms; collaborations for advancing biomarker research and exciting updates in biomarker research.

To build on the success of previous events, we are please to announce that the Biomarkers Congress will be co-located with the 3rd Annual Biomarkers in Clinical Development Congress, focusing on the role of biomarkers in clinical development, clinical trials and clinical diagnostics. Industry leaders will discuss the role of NGS & genomic markers in clinical diagnostics & decision making. Hear latest case studies on use of microRNA’s, CTCs and free circulating RNA & DNA as biomarkers in clinical diagnostics.

The Biomarkers Congress forms part of Oxford Global’s highly successful life science series. Upcoming events in the series include:


Sponsors 2016



Sponsors 2015




Media Partners